
Among two primary types of lung cancers, Small cell lung cancer is a rare and rapidly spreading type. While anyone might be affected, those who have smoked tobacco for a long time are usually the ones who are affected.
Type of Small Cell Lung Cancer (SCLC)
There are two major types of SCLC
What is the Importance of Timely Treatment?
Timely treatment of Small Cell Lung Cancer (SCLC) is essential for several reasons:
Small Cell Lung Cancer (SCLC) is better known for its aggressiveness and rapid progression. Here are some common symptoms:
Although smoking is the main cause of small cell lung cancer (SCLC), there are a number of other risk factors to take into account.
India has become a center for clinical trials aimed at treating SCLC. Many of these studies are looking into how combination of various treatments can work together to improve efficacy and overcome resistance mechanisms in SCLC., for example , According to recent studies, treating SCLC patients with Chemotherapy + Immunotherapy combination may benefit, especially if the disease is advanced and usually challenging to treat.
One innovative immunotherapy that is still in the experimental stage for SCLC is chimeric antigen receptor T-cell (CAR T-cell) therapy. It involves transforming the patient's own T-cells so they can identify and combat cancer cells. The success and safety of CAR T-cell therapy in SCLC are still being investigated, especially for patients whose disease is relapsed or resistent.
There are a few things you can do to lower your risk of developing Small Cell Lung Cancer (SCLC), particularly of the bladder, even if it is not always preventable:
Treatment options for Small Cell Lung Cancer (SCLC) differ based on the type and stage of the disease and the patient's overall health. The following are a few current treatments:
Lobectomy: Elimination of a lung lobe. The most popular procedure for SCLC in its early stages is this one.
Wedge Resection: This removes a little lung section with the tumor.
Segmentectomy: This is the Removal of a more prominent lung segment but not the entire lobe. Usually, this is applied to individuals with lung impairment or early-stage cancer.
Radiation Therapy: Treatments using high-energy rays to target cancer cells and reduce tumour size are known as radiation therapy. It may be used in combination with chemotherapy for Small Cell Lung Cancer (SCLC) or to relieve symptoms in advanced-stage SCLC.
Targeted Therapy : Drugs designed for particular forms of lung cancer are used in this treatment. Targeted therapy can locate and target specific cancer cells without endangering healthy cells. Although SCLC usually doesn't exhibit specific mutations like SCLC, studies are still being conducted on targeted treatments for particular genetic changes.
Cost Start From USD 8000 - USD 12000Explore Options
Immunotherapy : It emerged as a potentially effective treatment for SCLC, particularly for patients who have advanced stages of the disease or who experience a relapse following chemotherapy. Through immunotherapy, the body's immune system can better identify and combat cancer cells.
Cost Start From USD 3000 - USD 5000Explore Options
Chemotherapy : Chemotherapy is the use of medications that target lung cancer. It is among the most widely used therapies for SCLC. Chemotherapy may be prescribed by your oncologist alone or in conjunction with other treatments.
Cost Start From USD 600 - USD 700Explore Options
A variety of imaging tests, biopsies, and other techniques are used in the diagnosis of small cell lung cancer (SCLC) to detect and stage the malignancy. These are a few typical diagnostic choices:
Imaging Studies
Biopsy
Laboratory Tests
MediRehab (chain of Rehab centres - Part of MediGence) provides comprehensive rehabilitation services designed to support SCLC patients in India. These services include:
Depending on the circumstances, your doctor might recommend medication to help manage your symptoms and complement the course of treatment.









Pune, India
Ruby Hall Clinic located in Pune, India is accredited by NABH. Also listed below are some of the most prominent infrastructural details:

Hyderabad, India
Yashoda Hospital, Malakpet located in Hyderabad, India is accredited by NABH, NABL. Also listed below are some of the most prominent infrastructural details:

Ghaziabad, India
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
The cancer stage over diagnosis and the course of treatment have a substantial impact on the survival rate for SCLC. Early-stage treatment, such as radiation and chemotherapy, can provide better outcomes even in SCL, which tends to be very aggressive and spread quickly.
The treatment type and the stage of cancer determine how long SCLC treatment takes. Chemotherapy rounds, for example, mostly take 3-4 weeks. However, individuals may require multiple cycles according to how well they respond to the medication. Radiation therapy may take 2-6 weeks, depending upon the treatment strategy.
During and after treatment, these services provide emotional and psychological support, assist in managing side effects, and reduce discomfort. Programs for rehabilitation are also offered to assist patients in regaining their independence, confidence and physical strength.
In India, the type of treatment used and the cancer's stage at diagnosis have a significant impact on the success rate of treating small cell lung cancer (SCLC). When chemotherapy, radiotherapy, and immunotherapy are used to treat early-stage SCLC, positive results may be obtained.
The patient's general health, the stage of the cancer at diagnosis, and the efficacy of the treatment all affect the prognosis. Advanced treatment options and early discovery can increase survival rates.
Yes, one of the most prevalent forms of lung cancer in India is non-small cell lung cancer (NSCLC). About 80–85% of all incidences of lung cancer are caused by it.
In India, it is traditional practice to get a second opinion. In India, many hospitals and oncologists are willing to assess cases and offer second opinions on treatment strategies. One can:
Yes, MediGence offers a wide range of assistance to patients from other countries seeking treatment for non-small cell lung cancer. Most large hospitals offer specialised departments for international patients that help with accommodations, airport transfers, visa arrangements, and language translation.
To ensure that overseas patients have a seamless and hassle-free experience throughout their treatment journey, these departments also assist with financial information, appointment scheduling, and post-treatment care.